Royalty Pharma PLC
MEX : RPRXNMX$1,025.44+0.00%latest daily quote
Financials
A full-history view is not available for the cash flow statement yet. This is the statement exactly as one filing printed it.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
USD · reported units. Click a value to inspect its source.
| Reported line item | Jan 1, 2026 to Jun 30, 2026 (current) | Jan 1, 2025 to Jun 30, 2025 |
|---|---|---|
| StatementOfCashFlowsAbstract | ||
| NetCashProvidedByUsedInOperatingActivitiesAbstract | ||
| ProceedsFromCashCollectionsFromRoyaltiesReceivedOnFinancingReceivables | ||
| ProceedsFromCashCollectionsFromRoyaltiesReceivedOnIntangibleAssets | ||
| ProceedsFromCashCollectionsFromOtherRoyaltiesReceivedOnFinancingReceivables | ||
| EquityMethodInvestmentDividendsOrDistributions | ||
| ProceedsFromInterestReceived | ||
| PaymentsForDevelopmentStageFunding | ||
| PaymentsForOperatingCostsAndProfessionalServices | ||
| PaymentsForEmployeeEquityPerformanceAwards | ||
| InterestPaidNet | ||
| NetCashProvidedByUsedInOperatingActivities | ||
| NetCashProvidedByUsedInInvestingActivitiesAbstract | ||
| PaymentsToAcquireBusinessesNetOfCashAcquired | ||
| ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital | ||
| PaymentsToAcquireEquitySecuritiesFNNI | ||
| ProceedsEquitySecurities | ||
| PaymentsToAcquireAvailableForSaleSecuritiesDebt | ||
| ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | ||
| ProceedsFromAdditionalSalesOfAvailableForSaleDebtSecurities | ||
| PaymentsToAcquireFinanceReceivables | ||
| PaymentsForMilestones | ||
| PaymentsForProceedsFromOtherInvestingActivities | ||
| NetCashProvidedByUsedInInvestingActivities | ||
| NetCashProvidedByUsedInFinancingActivitiesAbstract | ||
| PaymentsToNoncontrollingInterestsPortfolioReceipts | ||
| PaymentsToMinorityShareholders | ||
| PaymentOfDividendsToShareholders | ||
| PaymentsForRepurchaseOfCommonStock | ||
| ProceedsFromNoncontrollingInterestsResearchAndDevelopment | ||
| ProceedsFromNoncontrollingInterestsOther | ||
| PaymentsOfDebtIssuanceCosts | ||
| ProceedsFromPaymentsForOtherFinancingActivities | ||
| NetCashProvidedByUsedInFinancingActivities | ||
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | ||
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | ||
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
33 line items · 2 reported periodsOriginal filing order · parentheses indicate negative amounts
Each column reflects this filing’s presentation. Original line items and period dates are preserved.